COVID-19 Post-Vaccination Observation

Sponsor

Yang I. Pachankis, PhD (Other)

Overall Status

Active, not recruiting

CT.gov ID

NCT06107348

Collaborator

(none)

Enrollment

Location

29.8

Anticipated Duration (Months)

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The study started after the second COVID-19 vaccination of the participant with blood spots appearing on the skin with severe arthritis. The study continued to the third-dose full vaccination of the participant with the recombined COVID-19 vaccination and afterwards. The study completed until intervention.

Condition or Disease	Intervention/Treatment	Phase
Immune System Diseases COVID-19 Vaccine Adverse Reaction Immune System Disorder

Study Design

Study Type:

Observational

Actual Enrollment :

1 participants

Observational Model:

Case-Only

Time Perspective:

Retrospective

Official Title:

COVID-19 Post-Vaccination Observation on Immune Exhaustion

Actual Study Start Date :

Jul 1, 2021

Actual Primary Completion Date :

Jan 4, 2023

Anticipated Study Completion Date :

Dec 24, 2023

Arms and Interventions

Arm	Intervention/Treatment
Immune Disorder

Outcome Measures

Primary Outcome Measures

Chemiluminescent Immunoassay for Human Immunodeficiency Virus [7 months]
Carcinoembryonic Antigen [7 months]
Alpha Fetoprotein [7 months]
Carbohydrate Antigen 19-9 [7 months]
Mucin-16 [7 months]
Cancer Antigen 15-3 [7 months]
Prostate-Specific Antigen [7 months]
Leukocytes [7 months]
Leukocyte Percentage [7 months]
Cholesterol [7 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 70 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

All COVID-19 vaccinated are eligible for inclusion.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Residential Address	Chongqing	Chongqing	China	402762

Sponsors and Collaborators

Yang I. Pachankis, PhD

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Pachankis YI. Questions of COVID-19: Institutional Derogations of Global Health. Lambert Academic Publishing. 2023. ISBN: 978-6206153849.

Responsible Party:

Yang I. Pachankis, PhD, PI, Pachankis, Yang I., M.D.

ClinicalTrials.gov Identifier:

NCT06107348

Other Study ID Numbers:

SARS-Immune-00

First Posted:

Oct 30, 2023

Last Update Posted:

Oct 30, 2023

Last Verified:

Oct 1, 2023

Individual Participant Data (IPD) Sharing Statement:

Yes

Plan to Share IPD:

Yes

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

COVID-19

Immune System Diseases

Study Results

No Results Posted as of Oct 30, 2023